Evidence map›Paper›PMID 42421282›Full record

ArticleJACC. Case reports2026

Secondary Giant Cardiac Lymphoma Treated by Stepwise Chemotherapy With Multimodal Imaging.

Shota Inoue, Koki Nakanishi, Yuriko Yoshida, Norihiko Takeda, Makoto Kurano

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shota InoueDepartment of Clinical Laboratory Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Koki NakanishiDepartment of Clinical Laboratory Medicine, The University of Tokyo Hospital, Tokyo, Japan; Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan. Electronic address: knakanishi82@gmail.com.
Yuriko YoshidaDepartment of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Norihiko TakedaDepartment of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Makoto KuranoDepartment of Clinical Laboratory Medicine, The University of Tokyo Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetastatic cardiac lymphoma is rare and may present as a large mass with a high risk of hemodynamic compromise and poor outcomes. CASE SUMMARY: A 79-year-old woman who had a history of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma and achieved remission after radiotherapy presented with dyspnea and edema. Transthoracic echocardiography and computed tomography revealed a large mass occupying the right atrium and ventricle. Biopsy confirmed diffuse large B-cell lymphoma, suggesting a late transformation of MALT lymphoma with cardiac involvement. Low-dose chemotherapy was initiated and gradually escalated with multimodal imaging guidance, resulting in marked mass regression without complications. DISCUSSION: Transformation of MALT lymphoma into diffuse large B-cell lymphoma can occur after long-term remission and present as isolated cardiac involvement. Stepwise chemotherapy may help reduce the risk of embolic events and cardiac rupture. TAKE-HOME MESSAGE: Serial multimodal imaging plays a pivotal role in monitoring the response to chemotherapy in patients with cardiac lymphoma.

Indexed as

computed tomographyechocardiographypositron emission tomography

Identifiers

PMID42421282
PMCPMC13523400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.